Skip to main content
Back
Watch Compare

aTYR PHARMA INC

Data quality: 100%
ATYR
Nasdaq Manufacturing Chemicals
$0.76
▼ $0.04 (-4.68%)
Mkt Cap: 74.75 M
Price
$0.76
Mkt Cap
74.75 M
Day Range
$0.76 — $0.80
52-Week Range
$0.64 — $7.29
Volume
951,207
Open $0.79
50D / 200D Avg
$0.88
13.22% below
50D / 200D Avg
$2.19
65.17% below

Quick Summary

Key Takeaways

Revenue declined -63.28% annually over 5 years
Negative free cash flow of -62.06 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 44.13%
Capital intensive — 40.53% of revenue goes to capex

Growth

Revenue Growth (5Y)
-63.28%
Below sector avg (9.35%)
Revenue (1Y)-19.15%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-95.59%
Below sector avg (-51.02%)
ROIC-69.30%
Net Margin-39009.47%
Op. Margin-40856.32%

Safety

Debt / Equity
N/A
Current Ratio5.93
Interest CoverageN/A

Valuation

PE (TTM)
-1.01
Above sector avg (-1.98)
P/B Ratio0.93
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -1.0 -2.0
P/B 0.9 5.1
ROE % -95.6 -51.0
Net Margin % -39009.5 -150.2
Rev Growth 5Y % -63.3 9.3
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -19.15% Revenue Growth (3Y) -26.63%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -63.28% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 190,000.0 Net Income (TTM) -74.12 M
ROE -95.59% ROA -71.20%
Gross Margin N/A Operating Margin -40856.32%
Net Margin -39009.47% Free Cash Flow (TTM) -62.06 M
ROIC -69.30% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.93
Interest Coverage N/A Asset Turnover 0.00
Working Capital 77.34 M Tangible Book Value 80.24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.01 Forward P/E N/A
P/B Ratio 0.93 P/S Ratio 393.44
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -83.02%
Market Cap 74.75 M Enterprise Value 68.60 M
Per Share
EPS (Diluted TTM) -0.80 Revenue / Share 0.00
FCF / Share -0.63 OCF / Share -0.63
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 40.53% FCF Conversion 83.74%
SBC-Adj. FCF N/A Growth Momentum 44.13

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 190,000.0 235,000.0 353,000.0 10.39 M 10.46 M
Net Income -74.12 M -64.02 M -50.39 M -45.34 M -33.77 M
EPS (Diluted) -0.80 -0.86 -0.94 -1.60 —
Gross Profit — — — — —
Operating Income -77.63 M -67.91 M -54.92 M -46.40 M -34.02 M
EBITDA — — — — —
R&D Expenses 60.22 M 54.37 M 42.29 M 42.81 M 23.26 M
SG&A Expenses — — — — —
D&A 664,000.0 708,000.0 592,000.0 232,000.0 475,000.0
Interest Expense — — — — —
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 93.00 M 96.83 M 120.65 M 95.79 M 115.54 M
Total Liabilities — — — — —
Shareholders' Equity 67.48 M 70.02 M 90.66 M 71.46 M 109.30 M
Total Debt — — — — —
Cash & Equivalents 10.74 M 11.06 M 22.54 M 9.98 M 2.34 M
Current Assets 80.24 M 81.95 M 102.99 M 80.87 M 113.57 M
Current Liabilities 15.15 M 14.97 M 16.42 M 13.86 M 6.01 M